Variant report
Variant | nsv965391 |
---|---|
Chromosome Location | chr3:109419757-109431296 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:73)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:109414982..109417591-chr3:109417920..109420582,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DPPA4-2 | chr3:109420303-109421065 | NONHSAT091126 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000271249 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562752957 | chr3:109419839-109419840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531514225 | chr3:109419861-109419862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186023009 | chr3:109419874-109419875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546666584 | chr3:109419914-109419915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564492856 | chr3:109419922-109419923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568054484 | chr3:109419928-109419929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386664508 | chr3:109419929-109419930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376093802 | chr3:109419937-109419938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533400877 | chr3:109419968-109419969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547109552 | chr3:109419969-109419970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566901350 | chr3:109420006-109420007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138933633 | chr3:109420017-109420018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191135175 | chr3:109420064-109420065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116152113 | chr3:109420069-109420070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569500571 | chr3:109420102-109420103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538179106 | chr3:109420112-109420113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551687638 | chr3:109420213-109420214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61353692 | chr3:109420220-109420221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1164063 | chr3:109420249-109420250 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs199781293 | chr3:109420252-109420253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183350767 | chr3:109420310-109420311 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs188022004 | chr3:109420326-109420327 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs553448019 | chr3:109420351-109420352 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs573654731 | chr3:109420353-109420354 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs192354921 | chr3:109420360-109420361 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs182614158 | chr3:109420372-109420373 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs58988227 | chr3:109420398-109420399 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs76184573 | chr3:109420456-109420457 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs541649323 | chr3:109420466-109420467 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs565220292 | chr3:109420497-109420498 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs202045781 | chr3:109420512-109420513 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs75025322 | chr3:109420513-109420514 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs561952808 | chr3:109420646-109420647 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs71323112 | chr3:109420648-109420649 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs368707443 | chr3:109420651-109420652 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs530113286 | chr3:109420660-109420661 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs570254678 | chr3:109420672-109420673 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs370925723 | chr3:109420753-109420754 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs529385504 | chr3:109420760-109420761 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs370642965 | chr3:109420763-109420764 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs549527816 | chr3:109420771-109420772 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs562919753 | chr3:109420785-109420786 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs531819648 | chr3:109420796-109420797 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs144142048 | chr3:109420814-109420815 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs571652846 | chr3:109420825-109420826 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs74839448 | chr3:109420829-109420830 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs533496039 | chr3:109420831-109420832 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs543905407 | chr3:109420835-109420836 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs146499069 | chr3:109420845-109420846 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs535986094 | chr3:109421006-109421007 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:109418600-109423600 | Enhancers | Dnd41 | blood |
2 | chr3:109420400-109420600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr3:109420600-109421000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:109420800-109422000 | Enhancers | HSMM | muscle |
5 | chr3:109421000-109422200 | Enhancers | NH-A | brain |
6 | chr3:109421000-109422400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:109421200-109421800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr3:109421400-109421800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr3:109421400-109421800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr3:109421400-109421800 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr3:109421400-109421800 | Enhancers | HMEC | breast |
12 | chr3:109421400-109421800 | Enhancers | HSMMtube | muscle |
13 | chr3:109423600-109426400 | Weak transcription | Dnd41 | blood |
14 | chr3:109426400-109427000 | Enhancers | Dnd41 | blood |
15 | chr3:109426600-109426800 | Enhancers | Pancreas | Pancrea |
16 | chr3:109426600-109427000 | Enhancers | Hela-S3 | cervix |
17 | chr3:109426800-109429000 | Weak transcription | Pancreas | Pancrea |
18 | chr3:109429000-109429400 | ZNF genes & repeats | Pancreas | Pancrea |
19 | chr3:109429200-109429400 | Enhancers | Gastric | stomach |